{
    "clinical_study": {
        "@rank": "158331", 
        "brief_summary": {
            "textblock": "RATIONALE: Radical prostatectomy may be an effective treatment for locally advanced prostate\n      cancer.\n\n      PURPOSE: Phase II trial to study the effectiveness of radical prostatectomy in treating\n      patients who have locally advanced prostate cancer."
        }, 
        "brief_title": "Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer", 
        "condition": "Prostate Cancer", 
        "condition_browse": {
            "mesh_term": "Prostatic Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the success rate of radical prostatectomy in patients with locally advanced\n           adenocarcinoma of the prostate.\n\n        -  Determine the serious toxic event rate of this surgery in these patients.\n\n        -  Determine the pN status of patients treated with this surgery.\n\n        -  Determine the percentage of patients found to have organ-confined tumors (pT2) after\n           undergoing this surgery.\n\n        -  Determine the 2-year prostate-specific antigen-free survival rate of patients treated\n           with this surgery.\n\n        -  Determine the surgical morbidity rates of patients treated with this surgery.\n\n      OUTLINE: This is a multicenter study.\n\n      Patients undergo limited pelvic lymphadenectomy and then radical retropubic prostatectomy.\n\n      Patients who are found to have pN-positive disease receive further treatment according to\n      the investigator's discretion. Patients with pN0 disease are followed every 3 months for 1\n      year and then every 4 months for 1 year.\n\n      PROJECTED ACCRUAL: A total of 32-74 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically confirmed adenocarcinoma of the prostate\n\n               -  Unilateral cT3a, cN0, M0\n\n          -  Well or moderately differentiated tumor\n\n               -  Gleason score no greater than 7 (4 plus 3 or 3 plus 4)\n\n          -  Total serum prostate-specific antigen no greater than 20 ng/mL (Hybritech equivalent)\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  70 and under\n\n        Performance status:\n\n          -  WHO 0-1\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  WBC greater than 3,000/mm^3\n\n          -  Platelet count greater than 100,000/mm^3\n\n          -  Hemoglobin greater than 9 g/dL\n\n        Hepatic:\n\n          -  Bilirubin no greater than 1.5 times normal\n\n          -  ALT or AST less than 3 times normal\n\n          -  PT and PTT normal\n\n        Renal:\n\n          -  Creatinine no greater than 1.5 mg/dL\n\n        Cardiovascular:\n\n          -  No preexisting uncontrolled cardiac disease, signs of cardiac failure, or rhythm\n             disturbances requiring therapy\n\n          -  No myocardial infarction within the past 6 months\n\n        Pulmonary:\n\n          -  No gross abnormalities on chest x-ray\n\n        Other:\n\n          -  No other disease that would preclude surgery\n\n          -  No other prior malignancy except adequately treated basal cell skin cancer\n\n          -  No other concurrent primary malignancy\n\n          -  No psychological, familial, sociological, or geographical condition that would\n             preclude compliance\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  Not specified\n\n        Endocrine therapy:\n\n          -  No prior hormonal therapy that would affect assessment of clinical T staging, margin\n             positivity, or definitive pT staging\n\n        Radiotherapy:\n\n          -  No prior pelvic radiotherapy that would affect surgical resectability and\n             perioperative morbidity\n\n        Surgery:\n\n          -  No prior surgery in the small pelvis (vascular surgery, mesh graft hernia repair, any\n             surgery for benign prostatic hypertrophy, or transurethral resection of prostate)\n             that would preclude prostatectomy"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 7, 2001", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00027794", 
            "org_study_id": "EORTC-30001", 
            "secondary_id": "EORTC-30001"
        }, 
        "intervention": {
            "intervention_name": "conventional surgery", 
            "intervention_type": "Procedure"
        }, 
        "keyword": [
            "adenocarcinoma of the prostate", 
            "stage III prostate cancer"
        ], 
        "lastchanged_date": "September 20, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-30001"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Hasselt", 
                        "country": "Belgium", 
                        "zip": "3500"
                    }, 
                    "name": "Virga Jesse Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium", 
                        "zip": "B-3000"
                    }, 
                    "name": "U.Z. Gasthuisberg"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy", 
                        "zip": "20132"
                    }, 
                    "name": "Istituto Scientifico H. San Raffaele"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Varese", 
                        "country": "Italy", 
                        "zip": "21100"
                    }, 
                    "name": "Ospedale di Circolo e Fondazione Macchi"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Martin", 
                        "country": "Slovakia", 
                        "zip": "03659"
                    }, 
                    "name": "Martin Faculty Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Italy", 
                "Slovakia"
            ]
        }, 
        "official_title": "Radical Prostatectomy for Locally Advanced Prostate Cancer. A Feasibility Study", 
        "overall_official": {
            "affiliation": "U.Z. Gasthuisberg", 
            "last_name": "Hein van Poppel, MD, PhD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "January 2005", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00027794"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": {
            "PMID": "16624554", 
            "citation": "Van Poppel H, Vekemans K, Da Pozzo L, Bono A, Kliment J, Montironi R, Debois M, Collette L. Radical prostatectomy for locally advanced prostate cancer: results of a feasibility study (EORTC 30001). Eur J Cancer. 2006 May;42(8):1062-7. Epub 2006 Apr 18."
        }, 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2001", 
        "study_design": "Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }, 
    "geocoordinates": {
        "Istituto Scientifico H. San Raffaele": "45.464 9.188", 
        "Martin Faculty Hospital": "49.063 18.922", 
        "Ospedale di Circolo e Fondazione Macchi": "45.818 8.826", 
        "U.Z. Gasthuisberg": "50.878 4.704", 
        "Virga Jesse Hospital": "50.931 5.332"
    }
}